| Index | — | P/E | 146.04 | EPS (ttm) | 0.25 | Insider Own | 2.72% | Shs Outstand | 116.31M | Perf Week | -0.54% |
| Market Cap | 4.25B | Forward P/E | 81.85 | EPS next Y | 0.45 | Insider Trans | -2.35% | Shs Float | 114.97M | Perf Month | 8.56% |
| Enterprise Value | 8.62B | PEG | 2.46 | EPS next Q | 0.11 | Short Float | 11.38% | Perf Quarter | -7.24% | ||
| Income | 29.00M | P/S | 3.91 | EPS this Y | -90.22% | Short Ratio | 9.79 | Perf Half Y | 10.84% | ||
| Sales | 1.09B | P/B | 0.79 | EPS next Y | 82.18% | ROA | 0.27% | Short Interest | 13.09M | Perf YTD | -2.30% |
| Book/sh | 46.45 | P/C | 33.18 | EPS next 5Y | 59.31% | ROE | 0.54% | 52W High | 43.58 -16.22% | Perf Year | -11.85% |
| Cash/sh | 1.10 | P/FCF | — | EPS past 3/5Y | 5.60% 7.31% | ROIC | 2.52% | 52W Low | 27.36 33.44% | Perf 3Y | 31.14% |
| Dividend Est. | 2.16 (5.92%) | EV/EBITDA | 13.82 | Sales past 3/5Y | 0.48% 4.39% | Gross Margin | 47.88% | Volatility | 2.48% 2.97% | Perf 5Y | -47.07% |
| Dividend TTM | 2.16 (5.92%) | EV/Sales | 7.94 | EPS Y/Y TTM | -90.77% | Oper. Margin | 23.27% | ATR (14) | 1.00 | Perf 10Y | -48.41% |
| Dividend Ex-Date | Sep 30, 2026 | Quick Ratio | 0.46 | Sales Y/Y TTM | -3.64% | Profit Margin | 2.63% | RSI (14) | 57.79 | Recom | 2.71 |
| Dividend Gr. 3/5Y | 0.63% 1.86% | Current Ratio | 0.46 | EPS Q/Q | -90.08% | SMA20 | 3.94% | Beta | 1.17 | Target Price | 37.75 |
| Payout | 895.65% | Debt/Eq | 0.83 | Sales Q/Q | -2.86% | SMA50 | 3.96% | Rel Volume | 0.95 | Prev Close | 36.07 |
| Employees | 241 | LT Debt/Eq | 0.83 | Earnings | Feb 08 | SMA200 | 5.86% | Avg Volume | 1.39M | Price | 36.51 |
| IPO Date | Jan 29, 1997 | Option/Short | Yes / Yes | EPS/Sales Surpr. | 3.84% 1.34% | Net Debt/EBITDA | 7.01 | Volume | 1,320,777 | Change | 1.22% |
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Oct-28-26 | Reiterated | Goldman Sachs | Sell | $31 → $32 |
| Sep-21-26 | Reiterated | Evercore ISI Group | Outperform | $38 → $44 |
| Sep-17-26 | Reiterated | Scotiabank | Sector Perform | $41 → $39 |
| Jul-21-26 | Reiterated | Barclays | Equal Weight | $39 → $38 |
| Jul-21-26 | Reiterated | Scotiabank | Sector Perform | $38 → $41 |
| Jul-21-26 | Reiterated | Mizuho | Underperform | $29 → $34 |
| Jun-16-26 | Reiterated | UBS | $44 | |
| Jun-16-26 | Upgrade | B of A Securities | Neutral → Buy | |
| Jun-15-26 | Reiterated | BMO Capital | Market Perform | $38 |
| Jun-08-26 | Upgrade | Evercore ISI Group | In Line → Outperform |
Kilroy Realty Corporation (NYSE: KRC) is a distinguished real estate investment trust (REIT) and a leading developer on the West Coast of the United States. Its operations span key markets including San Diego, Greater Los Angeles, the San Francisco Bay Area, and the Pacific Northwest. Globally celebrated for its commitment to sustainability, excellence in building operations, and groundbreaking innovation and design, KRC stands out. The company, a pioneer in fostering eco-friendly real estate, crafts modern work environments specifically designed to boost creativity, enhance productivity, and improve employee retention for prominent clients in technology, entertainment, life sciences, and business services sectors. As a publicly traded entity and an S&P MidCap 400 Index member, KRC brings over seven decades of expertise to the development, acquisition, and management of office and mixed-use properties. As of September 30, 2020, Kilroy Realty's stabilized portfolio encompassed approximately 14.3 million square feet, primarily comprising office and life science facilities, with an occupancy rate of 92.2% and a leased rate of 95.5%. Additionally, the company managed 808 residential units located in Hollywood and San Diego, which recorded average quarterly occupancy rates of 85.0% and 37.5%, respectively. Furthermore, KRC had seven development projects underway, representing an estimated total investment of $1.9 billion. These projects account for roughly 2.3 million square feet of new office and life science space, 90% of which was already leased.
Per-holder 13F data hasn't been ingested for this ticker yet.
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1,086 | 1,113 | 1,136 | 1,130 | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 566 | 367 | 373 | 351 | — | — | — | — | — | |
| Gross Profit | 520 | 746 | 763 | 779 | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 89 | 85 | 72 | 93 | — | — | — | — | — | |
| Research and Development | 0 | 0 | 0 | 0 | — | — | — | — | — | |
| Other Operating Expense | 178 | 345 | 356 | 356 | — | — | — | — | — | |
| Operating Income | 253 | 316 | 335 | 330 | — | — | — | — | — | |
| Interest Expense | 211 | 185 | 145 | 114 | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | -19 | 148 | 44 | 23 | — | — | — | — | — | |
| Net Income Before Taxes | 23 | 279 | 233 | 238 | — | — | — | — | — | |
| Income Taxes | 0 | 0 | 0 | 0 | — | — | — | — | — | |
| Consolidated Net Income | 29 | 276 | 211 | 212 | — | — | — | — | — | |
| Net Income From Continuing Operations | 23 | 279 | 233 | 238 | — | — | — | — | — | |
| Net Income | 29 | 276 | 211 | 212 | — | — | — | — | — | |
| EPS (Recurring) | 0.25 | 2.32 | 1.78 | 1.80 | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | 0.25 | 2.32 | 1.78 | 1.80 | — | — | — | — | — | |
| EPS (Diluted) | 0.25 | 2.32 | 1.77 | 1.80 | — | — | — | — | — | |
| EBITDA | 624 | 819 | 735 | 709 | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 146.04 | 16.11 | 22.85 | 22.13 | — | — | — | — | — | |
| Price To Sales Ratio | 3.90 | 4.00 | 4.20 | 4.13 | — | — | — | — | — | |
| Gross Margin | 47.88 | 67.03 | 67.17 | 68.94 | — | — | — | — | — | |
| Operating Margin | 23.30 | 28.39 | 29.49 | 29.20 | — | — | — | — | — | |
| Net Margin | 2.67 | 24.80 | 18.57 | 18.76 | — | — | — | — | — | |
| Shares Outstanding | 116 | 119 | 118 | 117 | — | — | — | — | — | |
| Market Capitalization | 4,235 | 4,447 | 4,773 | 4,661 | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Paratte A. Robert | Officer | Oct 27 '26 | Sale | 36.45 | 17,163 | 625,552 | 101,531 | Oct 28 |
| Hunt Jolie A. | Director | Jun 29 '26 | Sale | 37.79 | 15,800 | 597,099 | 13,892 | Jun 30 |
| Paratte A. Robert | Officer | Jun 24 '26 | Sale | 37.34 | 8,000 | 298,737 | 117,886 | Jun 25 |
| Smart Justin William | President | Jun 09 '26 | Sale | 38.71 | 10,848 | 419,904 | 519,872 | Jun 11 |
| Roth Heidi Rena | Officer | May 07 '26 | Sale | 35.22 | 19,541 | 688,187 | 83,173 | May 08 |
| Stadler Lauren N | Officer | May 06 '26 | Sale | 34.65 | 3,000 | 103,935 | 15,456 | May 07 |
| Paratte A. Robert | Officer | Apr 30 '26 | Sale | 33.11 | 10,000 | 331,130 | 125,886 | May 01 |
| Smart Justin William | President | Feb 05 '26 | Option Exercise | 0.00 | 134,097 | 0 | 530,735 | Feb 09 |
| Trencher Eliott | EVP, Chief Investment Officer | Feb 05 '26 | Option Exercise | 0.00 | 58,515 | 0 | 110,004 | Feb 09 |
| Paratte A. Robert | Officer | Feb 05 '26 | Option Exercise | 0.00 | 82,897 | 0 | 175,486 | Feb 09 |
| Roth Heidi Rena | Officer | Feb 05 '26 | Option Exercise | 0.00 | 48,763 | 0 | 123,529 | Feb 09 |
| Roth Heidi Rena | Officer | Oct 31 '25 | Sale | 41.99 | 3,944 | 165,592 | 69,413 | Nov 04 |
| Paratte A. Robert | Officer | Sep 18 '25 | Sale | 44.00 | 3,500 | 154,016 | 84,061 | Sep 19 |
| Werber Merryl Elizabeth | SVP, CAO, Controller | Aug 13 '25 | Sale | 38.28 | 6,250 | 239,253 | 26,435 | Aug 15 |
| Trencher Eliott | EVP, Chief Investment Officer | Aug 08 '25 | Sale | 38.05 | 3,997 | 152,071 | 43,826 | Aug 12 |